Verona Pharma: Strong Stock Growth Potential From A Promising New Drug03/12/2023 majac COPD This promising drug has the likely potential to achieve FDA approval to treat COPD (chronic obstructive pulmonary disease). Ensifentrine is also being …Share on FacebookTweetFollow usSave